Chemotherapy regimens maintenance chemotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Bone Marrow Tumor Cells, Cultured

Diseases79

Precursor Cell Lymphoblastic Leukemia-Lymphoma Lung Neoplasms Carcinoma, Small Cell Breast Neoplasms Recurrence Leukemia, Lymphoid Neoplasm Recurrence, Local Lymphoma, Non-Hodgkin Neutropenia Hodgkin Disease Nausea Neoplasm Metastasis Neoplasms Vomiting Carcinoma, Non-Small-Cell Lung Testicular Neoplasms Ovarian Neoplasms Colorectal Neoplasms Adenocarcinoma Neoplasms, Germ Cell and Embryonal Leukopenia Disease Progression Bone Neoplasms Brain Neoplasms Liver Neoplasms Thrombocytopenia Osteosarcoma Peritoneal Neoplasms Stomach Neoplasms Hematologic Diseases Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphatic Metastasis Carcinoma Germinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Leukemia, Myeloid, Acute Mediastinal Neoplasms Seminoma Sarcoma Retroperitoneal Neoplasms Lymphoma, B-Cell Central Nervous System Neoplasms Lymphoma, Follicular Stomatitis Fever Neoplasm, Residual Bone Marrow Diseases Pancreatic Neoplasms Biliary Tract Neoplasms Neoplasms, Second Primary Mesothelioma Multiple Myeloma Alopecia Burkitt Lymphoma Sarcoma, Ewing Medulloblastoma Leukemia, Myeloid Colonic Neoplasms Rectal Neoplasms Pleural Neoplasms Leukemia Neoplasms, Unknown Primary Esophageal Neoplasms Urologic Neoplasms Urinary Bladder Neoplasms Lymphoma, Mantle-Cell Amenorrhea Anemia Carcinoma, Transitional Cell Glioblastoma Fatigue Glioma Acute Disease Astrocytoma Lymphoma, AIDS-Related Melanoma Neuroblastoma

Chemicals and Drugs78

Cyclophosphamide 6-Mercaptopurine Methotrexate Vincristine Etoposide Cisplatin Doxorubicin Cytarabine Antineoplastic Agents Thioguanine Prednisone Daunorubicin Vinblastine Bleomycin Ifosfamide Paclitaxel Taxoids Carboplatin Deoxycytidine Anthracyclines Organoplatinum Compounds Antimetabolites, Antineoplastic Antineoplastic Agents, Alkylating Antineoplastic Agents, Phytogenic Lomustine Granulocyte Colony-Stimulating Factor Camptothecin Fluorouracil Dacarbazine Mitoxantrone Carmustine Antibiotics, Antineoplastic Antibodies, Monoclonal, Humanized Antiemetics Melphalan Bridged Compounds Platinum Compounds Mitomycin Antibodies, Monoclonal Epirubicin Antibodies, Monoclonal, Murine-Derived Mesna Tegafur Thiotepa Tumor Markers, Biological Procarbazine Leucovorin Vindesine Prednisolone Dexamethasone Oxonic Acid Altretamine Receptor, erbB-2 Platinum Asparaginase Prochlorperazine Quinazolines Angiogenesis Inhibitors Topotecan Idarubicin Fluoxymesterone Mitomycins Drug Combinations Tamoxifen Recombinant Proteins Receptors, Estrogen Antineoplastic Agents, Hormonal Vidarabine Mechlorethamine Dactinomycin Receptors, Progesterone Guanine Granisetron Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Nimustine P-Glycoprotein Ondansetron

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Maintenance Chemotherapy Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Drug Administration Schedule Disease-Free Survival Survival Analysis Remission Induction Clinical Trials as Topic Follow-Up Studies Survival Rate Neoplasm Staging Neoadjuvant Therapy Prognosis Salvage Therapy Infusions, Intravenous Transplantation, Autologous Induction Chemotherapy Prospective Studies Radiotherapy, Adjuvant Hematopoietic Stem Cell Transplantation Kaplan-Meier Estimate Randomized Controlled Trials as Topic Radiotherapy Clinical Trials, Phase III as Topic Actuarial Analysis Drug Evaluation Chemotherapy, Cancer, Regional Perfusion Radiotherapy Dosage Palliative Care Drug Therapy Multivariate Analysis Infusions, Intra-Arterial Administration, Oral Cranial Irradiation Pilot Projects Bone Marrow Transplantation Feasibility Studies Clinical Trials, Phase II as Topic Chemoradiotherapy Hematopoietic Stem Cell Mobilization Treatment Failure Retrospective Studies Proportional Hazards Models Risk Factors Maximum Tolerated Dose Random Allocation Immunohistochemistry Drug Therapy, Combination Drug Screening Assays, Antitumor Leukapheresis Predictive Value of Tests Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Tomography, X-Ray Computed Hyperthermia, Induced Karnofsky Performance Status Cohort Studies Blood Cell Count Double-Blind Method Immunotherapy Xenograft Model Antitumor Assays Risk Assessment Radioimmunotherapy Transplantation Conditioning Life Tables Patient Selection Retreatment Injections, Intravenous Leukocyte Count Probability Fatal Outcome Molecular Targeted Therapy Mastectomy Consolidation Chemotherapy Analysis of Variance Transplantation, Homologous

Phenomena and Processes11

Time Factors Drug Resistance, Neoplasm Dose-Response Relationship, Drug Maximum Tolerated Dose Apoptosis Drug Synergism Drug Resistance, Multiple Blood Cell Count Gene Expression Regulation, Neoplastic Leukocyte Count Probability

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Informatics Life Tables Fatal Outcome

Health Care33

Treatment Outcome Disease-Free Survival Survival Analysis Clinical Trials as Topic Follow-Up Studies Survival Rate Prospective Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Clinical Trials, Phase III as Topic Actuarial Analysis Palliative Care Multivariate Analysis Pilot Projects Feasibility Studies Clinical Trials, Phase II as Topic Treatment Failure Retrospective Studies Proportional Hazards Models Risk Factors Age Factors Random Allocation Predictive Value of Tests Karnofsky Performance Status Cohort Studies Double-Blind Method Risk Assessment Life Tables Patient Selection Probability Maintenance Fatal Outcome Analysis of Variance

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Maintenance Chemotherapy Antineoplastic Combined Chemotherapy Protocols Cyclophosphamide Chemotherapy, Adjuvant Combined Modality Therapy 6-Mercaptopurine Methotrexate Treatment Outcome Vincristine Drug Administration Schedule Disease-Free Survival Etoposide Precursor Cell Lymphoblastic Leukemia-Lymphoma Cisplatin Doxorubicin Lung Neoplasms Survival Analysis Cytarabine Antineoplastic Agents Thioguanine Remission Induction Prednisone Daunorubicin Clinical Trials as Topic Follow-Up Studies Survival Rate Carcinoma, Small Cell Breast Neoplasms Vinblastine Neoplasm Staging Bleomycin Time Factors Neoadjuvant Therapy Recurrence Ifosfamide Paclitaxel Prognosis Taxoids Leukemia, Lymphoid Carboplatin Deoxycytidine Anthracyclines Salvage Therapy Organoplatinum Compounds Neoplasm Recurrence, Local Lymphoma, Non-Hodgkin Neutropenia Antimetabolites, Antineoplastic Drug Resistance, Neoplasm Hodgkin Disease Nausea Neoplasm Metastasis Antineoplastic Agents, Alkylating Neoplasms Vomiting Carcinoma, Non-Small-Cell Lung Infusions, Intravenous Antineoplastic Agents, Phytogenic Lomustine Transplantation, Autologous Granulocyte Colony-Stimulating Factor Camptothecin Fluorouracil Dacarbazine Testicular Neoplasms Ovarian Neoplasms Dose-Response Relationship, Drug Induction Chemotherapy Colorectal Neoplasms Prospective Studies Mitoxantrone Adenocarcinoma Radiotherapy, Adjuvant Neoplasms, Germ Cell and Embryonal Leukopenia Carmustine Antibiotics, Antineoplastic Antibodies, Monoclonal, Humanized Antiemetics Hematopoietic Stem Cell Transplantation Kaplan-Meier Estimate Melphalan Bridged Compounds Platinum Compounds Mitomycin Randomized Controlled Trials as Topic Disease Progression Bone Neoplasms Brain Neoplasms Radiotherapy Antibodies, Monoclonal Epirubicin Liver Neoplasms Thrombocytopenia Clinical Trials, Phase III as Topic Actuarial Analysis Antibodies, Monoclonal, Murine-Derived Drug Evaluation Mesna Osteosarcoma

No FAQ available that match "chemotherapy regimens maintenance chemotherapy"